130 related articles for article (PubMed ID: 21411850)
1. Anakinra for the inflammatory complications of chronic granulomatous disease.
van de Veerdonk FL; Netea MG; Dinarello CA; van der Meer JW
Neth J Med; 2011 Feb; 69(2):95. PubMed ID: 21411850
[No Abstract] [Full Text] [Related]
2. Treatment With Anakinra, a Recombinant IL-1 Receptor Antagonist, Unlikely to Induce Lasting Remission in Patients With CGD Colitis.
Hahn KJ; Ho N; Yockey L; Kreuzberg S; Daub J; Rump A; Marciano BE; Quezado M; Malech HL; Holland SM; Heller T; Zerbe CS
Am J Gastroenterol; 2015 Jun; 110(6):938-9. PubMed ID: 26052777
[No Abstract] [Full Text] [Related]
3. Anakinra for Treatment of Liver Abscesses in a Patient with a Novel CYBB Variant of Chronic Granulomatous Disease.
To C; Williams A; Droney L
J Clin Immunol; 2021 Aug; 41(6):1368-1371. PubMed ID: 33822309
[No Abstract] [Full Text] [Related]
4. IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans.
de Luca A; Smeekens SP; Casagrande A; Iannitti R; Conway KL; Gresnigt MS; Begun J; Plantinga TS; Joosten LA; van der Meer JW; Chamilos G; Netea MG; Xavier RJ; Dinarello CA; Romani L; van de Veerdonk FL
Proc Natl Acad Sci U S A; 2014 Mar; 111(9):3526-31. PubMed ID: 24550444
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Schnitzler's syndrome with anakinra.
Gilson M; Abad S; Larroche C; Dhote R
Clin Exp Rheumatol; 2007; 25(6):931. PubMed ID: 18173934
[No Abstract] [Full Text] [Related]
6. IL-1 inhibition with anakinra in a patient with refractory gout.
Singh D; Huston KK
J Clin Rheumatol; 2009 Oct; 15(7):366. PubMed ID: 20009976
[No Abstract] [Full Text] [Related]
7. Uric acid induces NADPH oxidase-independent neutrophil extracellular trap formation.
Arai Y; Nishinaka Y; Arai T; Morita M; Mizugishi K; Adachi S; Takaori-Kondo A; Watanabe T; Yamashita K
Biochem Biophys Res Commun; 2014 Jan; 443(2):556-61. PubMed ID: 24326071
[TBL] [Abstract][Full Text] [Related]
8. Anakinra's efficacy is variable in refractory gout: report of ten cases.
Chen K; Fields T; Mancuso CA; Bass AR; Vasanth L
Semin Arthritis Rheum; 2010 Dec; 40(3):210-4. PubMed ID: 20494407
[TBL] [Abstract][Full Text] [Related]
9. Osteoarthritis: A single injection of anakinra for treating knee OA?
Martel-Pelletier J; Pelletier JP
Nat Rev Rheumatol; 2009 Jul; 5(7):363-4. PubMed ID: 19568251
[No Abstract] [Full Text] [Related]
10. Mechanisms of action of tumor necrosis factor antagonist and granulomatous infections.
Beenhouwer D; Wallis R; Broder M; Furst DE
J Rheumatol; 2004 Oct; 31(10):1888-92. PubMed ID: 15487038
[No Abstract] [Full Text] [Related]
11. Chronic granulomatous disease: recent advances in pathophysiology and treatment.
Seger RA
Neth J Med; 2010 Nov; 68(11):334-40. PubMed ID: 21116026
[TBL] [Abstract][Full Text] [Related]
12. Treating pulmonary silicosis by blocking interleukin 1.
Cavalli G; Fallanca F; Dinarello CA; Dagna L
Am J Respir Crit Care Med; 2015 Mar; 191(5):596-8. PubMed ID: 25723826
[No Abstract] [Full Text] [Related]
13. Successful treatment of macrophage activation syndrome complicating adult Still disease with anakinra.
Loh NK; Lucas M; Fernandez S; Prentice D
Intern Med J; 2012 Dec; 42(12):1358-62. PubMed ID: 23253002
[TBL] [Abstract][Full Text] [Related]
14. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease.
Romani L; Fallarino F; De Luca A; Montagnoli C; D'Angelo C; Zelante T; Vacca C; Bistoni F; Fioretti MC; Grohmann U; Segal BH; Puccetti P
Nature; 2008 Jan; 451(7175):211-5. PubMed ID: 18185592
[TBL] [Abstract][Full Text] [Related]
15. Remission of Schnitzler syndrome after treatment with anakinra.
Frischmeyer-Guerrerio PA; Rachamalla R; Saini SS
Ann Allergy Asthma Immunol; 2008 Jun; 100(6):617-9. PubMed ID: 18592830
[No Abstract] [Full Text] [Related]
16. Therapeutic strategy in p47-phox deficient chronic granulomatous disease presenting as inflammatory bowel disease.
Freudenberg F; Wintergerst U; Roesen-Wolff A; Albert MH; Prell C; Strahm B; Koletzko S; Ehl S; Roos D; Tommasini A; Ventura A; Belohradsky BH; Seger R; Roesler J; Güngör T
J Allergy Clin Immunol; 2010 Apr; 125(4):943-946.e1. PubMed ID: 20371400
[No Abstract] [Full Text] [Related]
17. Defective B-cell proliferation and maintenance of long-term memory in patients with chronic granulomatous disease.
Cotugno N; Finocchi A; Cagigi A; Di Matteo G; Chiriaco M; Di Cesare S; Rossi P; Aiuti A; Palma P; Douagi I
J Allergy Clin Immunol; 2015 Mar; 135(3):753-61.e2. PubMed ID: 25175493
[TBL] [Abstract][Full Text] [Related]
18. IL-1 blockade in Schnitzler syndrome: ex vivo findings correlate with clinical remission.
Ryan JG; de Koning HD; Beck LA; Booty MG; Kastner DL; Simon A
J Allergy Clin Immunol; 2008 Jan; 121(1):260-2. PubMed ID: 17936890
[No Abstract] [Full Text] [Related]
19. Inflammatory manifestations in chronic granulomatous disease (CGD).
Rosenzweig SD
J Clin Immunol; 2008 May; 28 Suppl 1():S67-72. PubMed ID: 18193341
[TBL] [Abstract][Full Text] [Related]
20. Enhanced inflammatory responses of chronic granulomatous disease leukocytes involve ROS-independent activation of NF-kappa B.
Bylund J; MacDonald KL; Brown KL; Mydel P; Collins LV; Hancock RE; Speert DP
Eur J Immunol; 2007 Apr; 37(4):1087-96. PubMed ID: 17330823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
